Filing Details

Accession Number:
0001127602-21-009293
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-03 19:30:15
Reporting Period:
2021-03-01
Accepted Time:
2021-03-03 19:30:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1741585 Marie Johonna Pelletier C/O Conmed Corporation
11311 Concept Boulevard
Largo FL 33773
Treasurer And Vp, Tax No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-01 1,900 $39.87 5,781 No 4 M Direct
Common Stock Disposition 2021-03-01 1,900 $123.03 3,881 No 4 S Direct
Common Stock Acquisiton 2021-03-01 2,000 $41.93 5,881 No 4 M Direct
Common Stock Disposition 2021-03-01 2,000 $122.55 3,881 No 4 S Direct
Common Stock Acquisiton 2021-03-01 6,100 $59.96 9,981 No 4 M Direct
Common Stock Disposition 2021-03-01 6,100 $122.34 3,881 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options To Purchase Common Stock Disposition 2021-03-01 1,900 $0.00 1,900 $39.87
Common Stock Options To Purchase Common Stock Disposition 2021-03-01 2,000 $0.00 2,000 $41.93
Common Stock Options To Purchase Common Stock Disposition 2021-03-01 6,100 $0.00 6,100 $59.96
Common Stock Options To Purchase Common Stock Acquisiton 2021-03-01 12,000 $0.00 12,000 $122.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-03-01 No 4 M Direct
2,000 2027-03-01 No 4 M Direct
5,400 2028-03-01 No 4 M Direct
12,000 2031-03-01 No 4 A Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.95 to $123.09. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.50 to $122.68. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.05 to $122.57. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  4. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
  5. The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period